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Regenerative medicineDirect conversion of ﬁbroblasts to induced cardiomyocytes (iCMs) has great potential for regenerative medicine.
Recent publications have reported signiﬁcant progress, but the evaluation of reprogramming has relied upon
non-functional measures such as ﬂow cytometry for cardiomyocyte markers or GFP expression driven by a
cardiomyocyte-speciﬁc promoter. The issue is one of practicality: themost stringentmeasures – electrophysiology
to detect cell excitation and the presence of spontaneously contracting myocytes – are not readily quantiﬁable in
the large numbers of cells screened in reprogramming experiments. However, excitation and contraction are
linked by a third functional characteristic of cardiomyocytes: the rhythmic oscillation of intracellular calcium
levels. We set out to optimize direct conversion of ﬁbroblasts to iCMs with a quantiﬁable calcium reporter to rap-
idly assess functional transdifferentiation.We constructed a reporter system inwhich the calcium indicatorGCaMP
is driven by the cardiomyocyte-speciﬁc Troponin T promoter. Using calcium activity as our primary outcome
measure, we compared several published combinations of transcription factors along with novel combinations
in mouse embryonic ﬁbroblasts. The most effective combination consisted of Hand2, Nkx2.5, Gata4, Mef2c, and
Tbx5 (HNGMT). This combination is >50-fold more efﬁcient than GMT alone and produces iCMs with cardio-
myocyte marker expression, robust calcium oscillation, and spontaneous beating that persist for weeks following
inactivation of reprogramming factors. HNGMT is also signiﬁcantlymore effective than previously published factor
combinations for the transdifferentiation of adult mouse cardiac ﬁbroblasts to iCMs. Quantiﬁcation of calcium
function is a convenient and effective means for the identiﬁcation and evaluation of cardiomyocytes generated
by direct reprogramming. Using this stringent outcome measure, we conclude that HNGMT produces iCMs
more efﬁciently than previously published methods.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.1. Introduction
Generation of cardiomyocytes by direct cellular reprogramming
provides a valuable source of cells for use in cardiovascular disease
research and treatment. Induced cardiomyocytes, or iCMs, may be
used for patient-speciﬁc drug toxicology screens, transplantations to
replace cells lost via myocardial infarction, and tomodel cardiac develop-
ment and disease in vitro. Unlike pluripotent cell-based strategies, direct
reprogramming also offers the tantalizing prospect of direct in situne, University of Pennsylvania,
Civic Center Blvd., Bldg. 421,
ax: +1 215 898 9871.
Addis), gearhart@upenn.edu
td. Open access under CC BY-NC-SA liconversions in the target organ. Great progress toward these goals has
been reported by several groups [1–5]; however, the effectiveness of car-
diac reprogramming remains controversial [6,7]. Published reports on the
in vitro generation of iCMs have relied upon some combination of GFP re-
porters, ﬂow cytometry, and RT-PCR for cardiomyocyte-speciﬁc markers
to evaluate the effectiveness of reprogramming procedures, with highly
variable results. We set out to optimize the conversion of ﬁbroblasts to
iCMs using a more stringent outcome measure — the calcium oscillation
that links excitation to contraction in functional cardiomyocytes.
Genetically-encoded calcium indicators (GECIs) are powerful tools for
the visualization of changes in intracellular calcium levels [8–10]. GCaMP
is a well-characterized GECI whose activity is comparable to traditional
calcium indicator dyes such as Fura-2 and Rhodamine-3 [11]. Unlike indi-
cator dyes, however, GECIs can be targeted specifically to cells or tissues of
interest using lineage-restricted gene promoters. Although most widely
used in the ﬁeld of neuroscience to study the calcium oscillations that un-
derlie neural activity [12–16], transgenic mice have been engineered to
speciﬁcally express GCaMP in smooth muscle [17] and cardiomyocytescense.
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bryonic stem cell-derived cardiomyocytes can electrically couple with
host myocytes upon transplantation to infarcted hearts [19]. In this re-
port, we describe the ﬁrst use of GCaMP as functional tool for the optimi-
zation of cardiac reprogramming.
The present study uses mouse embryonic ﬁbroblasts (MEFs) as
the starting cell population for initial reprogramming experiments.
MEFs were chosen for their ease of isolation from transgenic mouse
lines and their extensive history as a starting material for direct
reprogramming to a wide range of targets including pluripotent
stem cells [20], skeletal muscle [21], neurons [13,22,23], neural pro-
genitor cells [24], blood cells [25], hepatocytes [26,27], Sertoli cells
[28], and cardiomyocyte-like cells [3,29]. After determining the opti-
mal factor combination for MEF transdifferentiation, we extend this
method to the conversion of adult mouse cardiac ﬁbroblasts to iCMs.
2. Materials and methods
2.1. Plasmid construction
TroponinT-GCaMP5-Zeo vector: The ubiquitin promoter-rtTA cas-
sette of FUdeltaGW-rtTA (Addgene plasmid 19780)was excised and re-
placed with the human TNNT2 gene promoter (PCR-ampliﬁed from
System Biosciences plasmid SR10012PA-1) and a Gateway cassette
(PCR-ampliﬁed from pEF-DEST51, Invitrogen) to create TroponinT-
Gateway. The GCaMP5-2A-Zeo cassette was built by using recombinant
PCR to link the GCaMP5 sequence of pCMV-GCaMP5G [14] (Addgene
plasmid 31788) to the T2A-Zeocin sequence of System Biosciences plas-
mid SR10012PA-1. The GCaMP5-2A-Zeo cassette was cloned into
pDONR221 (Invitrogen), and subsequently into TroponinT-Gateway,
via Gateway recombination. All lentiviral backbone plasmids were
ampliﬁed in STBL3 bacteria (Invitrogen). Transcription factor open read-
ing frames (listed in Supplemental Table S1) were cloned into the
doxycycline-inducible (Tet-on) destination vector FU-tetO-Gateway
[13] using LR Clonase II (Invitrogen).
2.2. Lentivirus production
Second-generation lentiviral vectors were packaged in Lenti-X
293T cells (Clontech) using Lipofectamine 2000 (Invitrogen) to deliver
12 μg of the lentiviral backbone plasmid, 7.7 μg psPAX2 (Addgene
plasmid 12260) and 4.3 μg pMD2.G (Addgene plasmid 12259) in
3 mL OPTI-MEM (Invitrogen) to ~90% conﬂuent 100 mm plates of
293T cells with 10 mL fresh MEF medium. Viral supernatant (13 mL)
was collected at 24 and 48 h post-transfection, combined, and aliquoted
for storage at−80 °C. Viral titer was determined using Lenti-X GoStix
(Clontech). Lentiviruses used for all experiments had a minimum
titer of 5 × 105 IFU/mL. The TroponinT-GCaMP5-Zeo reporter lentivirus
was validated by transducing primary embryonic cardiomyocytes
(E14.5) on a poly-D-lysine-coated 35 mm FluoroDish (World Precision
Instruments) with 500 μL (≥2.5 × 105 IFU) of virus. GCaMP activity
was recorded 48 h post-transduction.
2.3. Preparation of primary cells
To prepare MEFs, embryos were harvested from mice of mixed
background at 14.5 dpc followed by decapitation and removal of inter-
nal visceral organs, including the heart. The tissue was minced, then
digested with trypsin and trituration, followed by resuspension of the
cells in DMEM with 10% fetal bovine serum and 2 mM L-glutamine
(MEF medium). The cells were plated on a 100 mm plate at a ratio of
one embryo per plate and allowed to expand for 24 h, at which time
they were passaged 1:3 for further expansion (passage 1). MEFs were
used at passages 3–5 for reprogramming experiments.
Primary embryonic cardiomyocytes were isolated at 14.5 dpc as
previously described [30].Cardiac ﬁbroblasts were isolated from adult mice (8–11 weeks old)
using a method adapted from Chen et al. [6]. Hearts were removed and
minced in cold PBS and then transferred to 4 mg/mL collagenase IV
(Sigma) and 10 U/mL deoxyribonuclease I (Worthington Biochemical
Corporation) and agitated at 37 °C for 10 min. Samples were spun
down and resuspended in TrypLE (Invitrogen) at 37 °C with agitation.
After 5 min, medium (DMEM supplemented with 15% FBS, 1% NEAA)
was added and the resulting solution was added to gelatin-coated 6
well plates. After 7 days, any remaining pieces of tissue were removed
and the cells were passaged 1:5 and frozen when conﬂuent. Cardiac
ﬁbroblasts were used at passage 3 for reprogramming experiments.
2.4. Direct conversion of ﬁbroblasts to iCMs
An outline of the reprogramming protocol is shown in Fig. 2A. MEFs
or adultmouse cardiac ﬁbroblastswere plated into poly-L-lysine-coated
glass-bottomed 6 well dishes (MatTek P06G-1.0-20-F) at 75,000 cells/
well on Day−2, with 500 μL (≥2.5 × 105 IFU) each of rtTA lentivirus
(FUdeltaGW-rtTA, Addgene plasmid 19780) and TroponinT-GCaMP-
Zeo reporter lentivirus per well with 2 mLMEFmedium. On the follow-
ing day (Day−1), culture medium was replaced with 2 mL fresh MEF
medium and the cells were transduced with 500 μL (≥2.5 × 105 IFU)
of each tetO-transcription factor lentivirus (thus, 2.5 mL total volume
of lentiviruses for HNGMT-mediated reprogramming). On the next
day (Day 0), the medium was switched to 3 mL/well Reprogramming
Medium consisting of AGM (Lonza CC-3186) without EGF, supple-
mented with 2 μg/mL doxycycline (Sigma). Fibroblasts were trans-
duced on Day 0 with 200 μL (≥1 × 105 IFU) of PGK-H2B-mCherry
[31] virus (Addgene plasmid 21217), which constitutively expresses
nuclear-localized mCherry red ﬂuorescent protein. Reprogramming
Medium was changed every 2–3 days.
2.5. Live imaging and quantiﬁcation of functional iCMs
Quantiﬁcation of GCaMP+ cells was achieved by comparing the
number of ﬂashing cells to the total cell number, the latter indicated
by the constitutively-expressed nuclear red ﬂuorescent marker,
PGK-H2B-mCherry [31]. To facilitate ﬂuorescent imaging of live
cells, reprogramming was performed on MEFs grown in glass-
bottomed 6 well dishes (MatTek P06G-1.0-20-F). To permit counting
of total cell number, MEFs were transduced on Day 0 with 200 μL
(≥1 × 105 IFU) of PGK-H2B-mCherry [31] virus (Addgene plasmid
21217), which constitutively expresses nuclear-localized mCherry red
ﬂuorescent protein. For GCaMP and mCherry imaging, the medium
was replaced with Tyrode's Salt Solution (Sigma T2397). 10 s movies
were made of 10–12 unique ﬁelds of view in a single well of a 6 well
dish with 10× Apo objective. After collecting video with the GFP ﬁlter
to view GCaMP, a brief segment of video was recorded with the
mCherry ﬁlter to visualize all nuclei. GCaMP+ cells were counted in
ImageJ and total cell number was obtained using the Nucleus Counter
plugin (MacBiophotonics ImageJ). A minimum of 3000 total cells were
counted per replicate, per condition. All GCaMP quantiﬁcation data is
the result of a minimum of 3 separate reprogramming experiments.
Imaging was performed on an Olympus iX-81 microscope with
Metamorph software. Movies were obtained using HyperCam software
(Hyperionics Technology). Statistical analysis (shown in Supplemental
Table S2) was conducted using a one-way ANOVA with Tukey's
post-hoc testing. The GCaMP intensity traces shown in Figs. 1B, 2B, 4C,
and 6B were made using the “Intensity v Time Monitor” plugin in
ImageJ.
2.6. Immunocytochemistry
Immunostaining was performed as previously described [13].
Brieﬂy, cells for immunostaining were grown on 12 mm glass coverslips
coated with poly-L-lysine (BD Biocoat 354085), with 4–5 coverslips per
Fig. 1. The TroponinT-GCaMP5 calcium reporter. A) The Troponin T (TNNT2) gene promoter drives expression of the genetically-encoded calcium indicator, GCaMP5, and a zeocin
resistance cassette. The GCaMP protein consists of a Ca2+-sensitive calmodulin domain fused to GFP. When intracellular Ca2+ is low, the calmodulin domain blocks proper folding
of GFP, resulting in a low level of GFP ﬂuorescence. When intracellular Ca2+ is high, the calmodulin domain shifts to permit GFP folding and bright ﬂuorescence. B) Validation of the
TroponinT-GCaMP5 reporter in embryonic cardiomyocytes. Ventricular cardiomyocytes were isolated from mouse embryos at 14.5 dpc and transduced with reporter lentivirus.
GCaMP activity was recorded 48 h post-transduction. The left panel corresponds to a single frame of Supplemental Movie S1. White arrows indicate regions examined for oscillating
ﬂuorescence, shown in the right panel. RFU, Relative Fluorescence Units calculated using the “Intensity v Time Monitor” in ImageJ software.
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anti-cardiac Troponin T (Thermo MS-295-P, 1:200); mouse anti-myosin
heavy chain clone MF20 (eBioscience 53-6503-82, 1:200); mouse anti-
sarcomeric α-actinin (clone EA-53, Sigma A7811, 1:200); rabbit anti-
smooth muscle myosin heavy chain (Abcam ab53219, 1:200); goat
anti-Mesp1 (Santa Cruz Biotechnology sc-163078, 1:100); rabbit anti-
von Willebrand factor (Abcam ab6994, 1:100); rabbit anti-Isl1 (Abcam
ab20670, 1:100); rabbit anti-CD31 (Abcam ab28364, 1:100); goat anti-
Nkx2.5 (Santa Cruz Biotechnology sc-8697, 1:100).
2.7. Microarray
Mouse genome-wide expression analyses were performed using
the Affymetrix Mouse Gene 1.0 ST Array. iCMs were enriched by
selecting for zeocin resistance driven by the TroponinT-GCaMP5-Zeo
reporter and collected in Trizol at Day 21 post-transduction (7 days
after initiation of zeocin selection, 300 μg/mL). Non-transduced
MEFs were cultured and collected at Day 21. Samples were collected
in triplicate from independent biological replicates and total RNA
was prepared by the University of Pennsylvania Molecular Proﬁling
Facility. Microarray analyses were performed with standard Affymetrix
GeneChip Expression protocols. Initial data analysis was performed
using Affymetrix Microarray Suite 5.0 and further analyzed using
PartekGS software. The heat map in Fig. 5A was generated using
Multi ExperimentViewer (http://www.tm4.org/). Completemicroarray
dataset has been deposited in theGEOdatabase (Accession#GSE45274).
Expression levels of selected genes identiﬁed via microarray analysis
were validated using quantitative RT-PCR.
2.8. Quantitative RT-PCR
RNAwas collected using the RNeasyMini Kit (Qiagen) andﬁrst-strand
cDNA synthesis was performed using Superscript III reverse transcriptase
(Invitrogen) with random hexamer primers. Quantitative real-time
PCR was performed on an ABI 7900HT system (Applied Biosystems)
using the following TaqMan gene expression assays: beta actin
(Mm00607939_s1), 18S RNA (Hs99999901_s1), Mesp1 (Mm00801883_
g1), Isl1 (Mm00627860_m1), Nkx2.5 (Mm00657783_m1), Cacna1c(Mm01188822_m1), Casq2 (Mm00486742_m1), Jph2 (Mm00517621_
m1), Pln (Mm04206541_m1), Ryr2 (Mm00465877_m1), and Atp2a2
(Mm01201431_m1).
2.9. Generation of cardiac progenitor cells and cardiomyocytes from
embryonic stem cells
To generate CPCs for use as a positive control in RT-PCR studies,
mouse embryonic stem cells (line D3, passage 27) were differentiated
as described by Kattman et al. [32]. Brieﬂy, cells at passage 25 were
transitioned to serum-free growth medium (Knockout DMEM/F12
(Invitrogen) supplemented with 0.5× of both N2 and B27 supplements
(Invitrogen), 1× Glutamax (Invitrogen), 1× penicillin–streptomycin
(Invitrogen), 0.05% BSA (Invitrogen), 1000 U/mL LIF (Millipore),
0.15 mM 1-thioglycerol (Sigma), and 10 ng/mL BMP4 (R&D Systems))
for two passages onto gelatin-coated 100 mm plates without feeders.
On Day 0, ES cells were dissociated using TrypLE Express (Invitrogen)
and differentiated as embryoid bodies in serum-free medium con-
sisting of 75% Iscove's modiﬁed Dulbecco's medium (Invitrogen) and
25% Ham's F12 medium (Invitrogen) supplemented with 0.5× N2 and
B27 without retinoic acid supplements (Invitrogen), 1× penicillin–
streptomycin, 0.05% BSA, 4.5 mM 1-thioglycerol and 50 μg/mL ascorbic
acid (Sigma) at 100,000 cells/mL in non-tissue culture-treated 100 mm
plates without addition of any growth factors. After 48 h, the embryoid
bodies were dissociated and reaggregated at 150,000 cells/mL in the
aforementioned differentiation medium supplemented with 5 ng/mL
human VEGF (R&D Systems), 0.5 ng/mL human BMP4 (R&D Systems),
and 8 ng/mL human Activin A (R&D Systems). Unsorted and Flk-1+/
PDGFRα+ cells were collected at Day 3.75 for RNA isolation.
To generate ES-derived cardiomyocytes for validation of the
TroponinT-GCaMP vector, whole embryoid bodies were plated on
Day 3.75 onto ﬁbronectin-coated FluoroDishes in ES Differentiation
Medium consisting of StemPro34 with StemPro Nutrient Supplement
(Invitrogen), 1×Glutamax, 1 mMascorbic acid (Sigma), 2.5 μMXAV939
(Cayman Chemical), 5 ng/mL VEGF (R&D Systems), 10 ng/mL bFGF
(R&D Systems), and 12.5 ng/mL FGF10 (R&D Systems). Cells were
transduced on Day 4 with 500 μL (≥2.5 × 105 IFU) of TroponinT-
GCaMP5-Zeo reporter lentivirus. GCaMP activity in ES-derived
Fig. 2. Functional quantiﬁcation of direct ﬁbroblast reprogramming to induced cardiomyocytes. A) Schematic of direct ﬁbroblast reprogramming to induced cardiomyocytes (iCMs).
B) GCaMP activity in beating iCMs, 14 days post-induction. The left panel corresponds to a single frame of Supplemental Movie S4, which shows Ca2+ ﬂux in spontaneously beating
iCMs generated by HNGMT treatment, overlaid with a red ﬂuorescent image to show the PGK-H2B-mCherry vector that was used to quantify total cells. The right panel traces
oscillations in GCaMP ﬂuorescence, corresponding to oscillations in intracellular Ca2+, at the regions marked by the white arrows. Scale bar 50 μm. RFU, Relative Fluorescence
Units calculated using the “Intensity v Time Monitor” in ImageJ software. C) Quantiﬁcation of functional iCMs using GCaMP activity. Functional iCMs were identiﬁed on the
basis of repeated GCaMP oscillation in 10 s movies made at 14 days post-induction. Activity is expressed as the percentage of cells displaying repeated GCaMP oscillation in
10 s movies divided by the total number of cells per ﬁeld. Data are presented as means ± SEM. ⁎ denotes p b 0.05 in comparison to GMT.
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identiﬁable.
3. Results
3.1. Validation of the TroponinT-GCaMP calcium reporter
Weconstructed aGCaMP reporter lentivirus that allows for real-time
detection of calcium ﬂux in live cells driven by the cardiomyocyte-
speciﬁc Troponin T (TNNT2) promoter (Fig. 1A). The effectiveness of
the TroponinT-GCaMP5-Zeo reporter lentiviruswas tested in ventricular
cardiomyocytes isolated from mouse embryos at 14.5 dpc. As shown
in Fig. 1B and Supplemental Movie S1, the reporter vector drives
cardiomyocyte-speciﬁc expression of GCaMP5, a protein that exhibits
bright green ﬂuorescence in the presence of high intracellular Ca2+
levels and dim ﬂuorescence with low Ca2+. Thus, the rhythmicoscillation of intracellular Ca2+ that couples excitation and contraction
in cardiomyocytes can be readily observed using a standard GFP ﬁlter
on a ﬂuorescent microscope. The TroponinT-GCaMP5 vector was also
effective for visualizing calcium ﬂux in embryonic atrial cardiomyocytes
as well as embryonic stem cell-derived cardiomyocytes (shown in
Supplemental Fig. S1 and Movies S2 and S3).
3.2. Evaluation of transcription factor combinations for their capacity to
convert ﬁbroblasts into induced cardiomyocytes
Mouse embryonic ﬁbroblasts were transduced with doxycycline-
inducible lentiviral vectors to drive expression of cardiac transcription
factors. In combination with the reverse tetracycline transactivator
(rtTA), these vectors allow for the activation and inactivation of
transgene expression using Tet-on regulation. Each lentiviral vector
contains a single transcription factor Open Reading Frame (listed in
101R.C. Addis et al. / Journal of Molecular and Cellular Cardiology 60 (2013) 97–106Supplemental Table S1). Viral transduction efﬁciency was determined
to be >95% using immunostaining for the V5 epitope tag present at
the C-terminus of transcription factors in the tetO-Gateway vector
(shown in Supplemental Fig. S2). Initial studies compared the previous-
ly published 3-factor combination of Gata4, Mef2c, and Tbx5 (GMT) [1]
with a 4-factor combination consisting of GMT plus Nkx2.5 (NGMT).
NGMT proved more effective than GMT for the generation of putative
iCMs, as indicated by immunostaining for α-myosin heavy chain,
cardiac Troponin T, and sarcomeric α-actinin (Figs. S3 and S4). NGMT
also produced functional cardiomyocytes, with 0.7 ± 0.3% of cells
exhibiting GCaMP activity at 14 days post-induction compared to
0.03 ± 0.02% for GMT (Fig. 2C), a 22.5-fold increase over GMT. When
we compared the more recently published combination of GMT plus
Hand2 (HGMT) [5], an increased number of functional iCMs (1.3 ±
0.1%) was detected. To determine whether the enhancing effects of
Nkx2.5 and Hand2 were overlapping, we added both factors to GMT
and found greater enhancement of functional iCM generation
(HNGMT, 1.6 ± 0.3% GCaMP+), a 52-fold increase over GMT alone.
In addition, we compared the recently published combination of
Myocardin, Mef2c, and Tbx5 (DMT, 0.06 ± 0.01%) [3] and DMT plus
Nkx2.5 (DMNT, 0.4 ± 0.2%). Representative GCaMP + iCMs gener-
ated with HNGMT are shown in Fig. 2B, which is a single frame of
Supplemental Movie S4 overlaid with a red ﬂuorescent image to show
the PGK-H2B-mCherry vector that was used to quantify all cells in a
given ﬁeld of view. GCaMP activity was detected as early as 6 days
post-induction, with robust calcium ﬂux and spontaneous beating
evident by Day 14, as shown in Supplemental Movie S5. In MEFs that
were not transduced with transcription factor lentiviruses, rare (fewer
than 1 in 1000) cells exhibited steady green ﬂuorescence, likely due to
integration of the reporter vector in genomic regions of high transcrip-
tional activity. However, no oscillations in GCaMP ﬂuorescence were
detected in MEFs that did not receive transcription factors, with greater
than 2 × 107 cells analyzed.3.3. Immunocytochemical analysis of induced cardiomyocytes
Immunostaining for cardiomyocyte markers revealed expression
of α-myosin heavy chain, cardiac Troponin T, and α-actinin, with
sarcomere structure clearly visible (Fig. 3). α-Actinin staining was
performed using antibody clone EA-53, which does not recognize
smooth muscle actinin [33]. Staining for smooth muscle myosin
heavy chain (Myh11), a marker that exclusively labels smoothmuscleFig. 3. Immunocytochemical analysis of Day 14 iCMs. Cardiomyocyte markers cardiac Tropo
in HNGMT-iCMs. Regions in white boxes are enlarged in insets to show sarcomere structure.
heavy chain (smMHC, Myh11). DAPI stain (blue) marks nuclei. Scale bars 50 μm.cells during mouse embryonic development [34], revealed that
all combinations tested produced putative smooth muscle cells in
addition to iCMs (Fig. 3B and Supplemental Fig. S4). No expression
of α-myosin heavy chain, cardiac Troponin T, α-actinin, or smooth
muscle myosin heavy chain was detected in cells that were not trans-
duced with transcription factor lentiviruses (Supplemental Figs. S3
and S4) or in cells that were singly transduced with individual
transcription factor vectors (data not shown). Vascular endothelial
markers (CD31 and von Willebrand factor) were not detected, sug-
gesting that the reprogramming process did not involve a tripotent
cardiac progenitor cell intermediate. In HNGMT-treated wells, rare
cells were identiﬁed that stained double-positive for markers of
smooth muscle and cardiomyocytes (as seen in Supplemental Fig. S4).
Combinations DMT and DMNT induced widespread expression of
smooth muscle myosin heavy chain, a ﬁnding that is consistent with
the known role ofMyocardin as a key regulator of smoothmuscle devel-
opment [35].
3.4. Proliferation of iCMs was not detected
To evaluate whether iCMs were proliferative, we performed
immunocytochemistry for the proliferation marker Ki67 along with
the cardiomyocyte marker cardiac Troponin T beginning on Day 0 and
continuing for every other day until Day 14 (shown in Supplemental
Fig. S5). Both GMT- and HNGMT-treatedMEFswere analyzed. Although
Ki67+ cells (presumably proliferating ﬁbroblasts) could be detected
for several days following factor induction, no Ki67+/cTnT+ cells
were detected at any timepoint, suggesting that iCMs do not proliferate.
Therefore, percentages of GCaMP+ cells at Day 14 post-induction are
likely an underrepresentation of conversion efﬁciency given the con-
tinued proliferation of non-reprogrammed MEFs. Wells that began
with 75,000 cells at initial plating contained an average of 2.04 × 106
cells on Day 14 (across all reprogramming conditions).
3.5. Markers of cardiac progenitor cells were not detected in MEFs
Although MEFs were prepared from embryos following removal of
the viscera, including the developing cardiovascular system, we consid-
ered the possibility that other embryonic tissues, such as the neural
crest, might contribute migratory cardiac progenitors to the MEF popu-
lation [36,37]. We evaluated untreatedMEFs for their expression of Isl1,
a gene expressed by cardiac progenitor cells of both second heart ﬁeldnin T (cTnT), α-myosin heavy chain (α-MHC), and sarcomeric α-actinin are expressed
Putative smooth muscle cells were also detected by staining for smooth muscle myosin
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cardiac cell fate [38], and Nkx2.5. None of these markers were detected
via either quantitative RT-PCR (as shown in Supplemental Fig. S6) or
immunocytochemistry (data not shown).3.6. Analysis of iCM stability upon inactivation of reprogramming factors
To determine the stability of the reprogrammed iCM phenotype as
well as the minimum duration of factor expression required to drive
reprogramming, we examined the effect of turning off exogenous
HNGMT at various timepoints. We compared continuous factor expres-
sion (in the continued presence of doxycycline) to doxycycline removal
after 5, 10, and 15 days (Fig. 4A). Although induction for 5 days was
sufﬁcient to generate GCaMP+ cells (0.6 ± 0.2% at Day 14 post-
induction), functional iCMs could not be detected at later timepoints.
This suggests that short-term factor expression produces cells that
are only partially reprogrammed.With 10 ormore days of factor induc-
tion, however, functional iCMs persisted after the inactivation of exog-
enous transcription factor expression. This was further demonstrated
by immunostaining for sarcomeric α-actinin 28 days post-induction
(Fig. 4B). No iCMs with sarcomeric structure were detected in the
conditionwith 5 days of HNGMT expression. Although 10 days of factor
induction were sufﬁcient to generate iCMs, the percentage of GCaMP+
cells in this condition declined over time, a trend not observed in
cells that received 15 days of factor induction. GCaMP+, beating iCMs
could still be found 3 weeks following doxycycline removal (shown in
Fig. 4C and Supplemental Movie S6).3.7. Microarray analysis and assessment of genes that encode the
excitation–contraction complex
To generate an enriched population of iCMs, we made use of the
zeocin resistance gene present in the TroponinT-GCaMP reporter by
adding zeocin to the culture medium on Day 14 post-induction and
collecting RNA for microarray analysis on Day 21. Expression data
for selected genes are presented in Fig. 5A, with genes that are
down-regulated relative to untransduced MEFs depicted in green
and up-regulated genes in red. For all transcription factor com-
binations tested, expression of ﬁbroblast genes [26] was down-
regulated, consistent with the loss of ﬁbroblast identity. All combina-
tions also exhibited up-regulation of cardiomyocyte genes, with
some of the highest expression levels detected in combinations that
included Myocardin (DMT and DMNT). This is in agreement with
a previous report of the effectiveness of DMT at up-regulating
cardiomyocyte markers [3]. However, DMT and DMNT also showed
substantial up-regulation of smooth muscle markers including smooth
muscle myosin heavy chain (Myh11), transgelin (Sm22/Tagln), and
calponin (Cnn1). As noted above, these results are indicative of the
dual role of Myocardin in promoting both cardiomyocyte and smooth
muscle cell fates.
To gain insight into the mechanism by which certain factor combi-
nations produce greater numbers of functional iCMs, we examined
the expression of genes encoding the complex set of proteins that
mediate Ca2+ ﬂux to couple excitation with contraction (a diagram
of these proteins is presented as a visual aid in Fig. 5B, adapted
from [39] and [40]). Gene expression data obtained via microarray
analysis was conﬁrmed using quantitative RT-PCR and normalized
to expression levels present in embryonic cardiomyocytes (E14.5).
As shown in Fig. 5C, key components of the excitation–contraction
complex were expressed in iCMs. In particular, calsequestrin and
phospholamban were most highly up-regulated in the transcription
factor combinations that produced the largest percentages of functional
iCMs (HGMT andHNGMT), with statistically signiﬁcant increases versus
GMT (p b 0.05).3.8. HNGMT effectively converts adult cardiac ﬁbroblasts to iCMs
Having established that HNGMT was the optimal factor combina-
tion for MEF reprogramming, we tested whether this method was
also effective in adult mouse cardiac ﬁbroblasts (aMCFs), cells that
are the target of in vivo transdifferentiation strategies. HNGMT was
compared to GMT and HGMT, two combinations that have been pre-
viously shown to convert cardiac ﬁbroblasts to iCMs [1,5]. As shown
in Fig. 6A, all three combinations successfully generated functional
iCMs. HNGMT yielded the highest percentage of cells with GCaMP os-
cillation at Day 14 post-induction (4.5 ± 0.3%), a statistically signiﬁ-
cant increase over both GMT (p = 9.1e−5) and HGMT (p = 0.017).
A typical beating, GCaMP+ iCM derived from aMCFs is shown in
Fig. 6B and Supplemental Movie S7. As was the case in MEF-derived
iCMs, aMCF-derived iCMs exhibit robust expression of cardiomyocyte
markers cTnT, α-MHC, and α-actinin, with sarcomeric organization
(Fig. 6C and D). Putative smooth muscle cells (determined by immu-
nostaining for smMHC) were also detected (Fig. 6D).
4. Discussion and conclusions
Ourwork demonstrates a robust, convenientmethod for the quanti-
ﬁcation of ﬁbroblast reprogramming to functional cardiomyocytes.
The TroponinT-GCaMP reporter is scalable; it can be used to monitor
calcium oscillations in a single cell or to evaluate the functionality
of thousands of cells simultaneously. Calcium activity cannot be directly
equated to spontaneous contraction — although every contracting
iCM exhibited GCaMP oscillation, not every GCaMP positive cell is
overtly contracting. Cells may begin to cycle calcium before excitation–
contraction coupling or sarcomere assembly is complete. It is therefore
most accurate to consider calcium oscillation to be a functional outcome
measure in its own right. Since it requires an orchestrated process in-
volvingmultiple proteins, it is amore stringentmeasure than the activa-
tion of a single gene or marker. Our technique allows for quantitative
comparisons between different protocols in a mid-throughput system.
The present study focused on mouse embryonic ﬁbroblasts; future
work will determine whether the HNGMT combination is effective
at direct in situ reprogramming of cardiac ﬁbroblasts. The ﬁnding
that iCMs remain stably reprogrammed long after the removal of
exogenous reprogramming factors is encouraging. The minimum
requirement of approximately ten days of factor expression to effect
reprogramming is consistent with reports of transdifferentiation to
other cell types [13,41]. However, it is also evident that short-term
exposure to reprogramming factors can produce unstable cells that
are not fully converted. Furthermore, the beating iCMs generated in
this study are likely immature, given that adult cardiomyocytes do
not beat spontaneously in cell culture [42–44]. These ﬁndings raise
potential concerns for the safety of in vivo reprogramming strategies
that will need to be evaluated. Future work will determine whether
iCMs generated both in vitro and in vivo can undergo maturation to
adult cardiomyocytes. It will also be important to identify the subtype
of iCMs (i.e. atrial, ventricular, or nodal) and investigate whether
different combinations of reprogramming factors produce iCMs of
different subtypes. Interestingly, the shape of GCaMP traces appears
to be slightly different in embryonic cardiomyocytes isolated from
atria and ventricles. It will be necessary to combineGCaMP phenotyping
with electrophysiology to determine whether cardiomyocyte subtypes
can be identiﬁed by calcium traces alone.
Consistent with a previous study of reprogramming in MEFs [3],
factor combinations that included Myocardin exhibited substantial
upregulation of cardiomyocyte markers. However, very little calcium
oscillation was detected and immunostaining revealed simultaneous
expression of cardiomyocyte and smooth muscle proteins in virtually
all putative iCMs. It is possible that the concurrent expression of
cardiomyocyte and smooth muscle transcriptional programs prevents
either cell fate from being fully adopted. Indeed, ectopic expression
Fig. 4. Stability of the reprogrammed iCM phenotype. A) GCaMP activity was quantiﬁed at 14, 21, and 28 days post-induction, comparing HNGMT-treated cells with doxycycline
applied continuously or withdrawn at 5, 10, or 15 days post-induction. Data are presented as means ± SEM. Beating, GCaMP + iCMs could be detected on Day 28 for all conditions
excepting Day 5 Dox removal. B) Immunostaining for sarcomeric α-actinin (red) in representative HNGMT-iCMs, 28 days post-induction. DAPI stain (blue) marks nuclei. Scale bars
50 μm. C) GCaMP activity recorded on Day 36 post-induction, with doxycycline removed on Day 15 (thus 3 weeks without exogenous transcription factor induction). Right panel
shows oscillation in GCaMP ﬂuorescence at the region indicated by the white arrow, left. Left panel is a single frame of Supplemental Movie S6, which shows both GCaMP activity
and robust cell contraction. Scale bar 50 μm.
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scription of both cardiomyocyte and smooth muscle genes [45]. Since
smooth muscle cells also exhibit calcium oscillations [17], we cannotrule out the possibility that the GCaMP activity seen in cells treated
with DMT and DMNT is consistent with a smooth muscle, rather than
cardiomyocyte, phenotype. It is likely that reprogramming strategies
Fig. 5. iCM gene expression analysis and assessment of components of excitation–contraction coupling. A) Heat map showing expression data for selected genes in microarray analysis.
Microarrays were performed on RNA collected from putative iCMs on Day 21 post-induction. Expression is normalized to untreatedMEFs, with positive fold changes indicated in red and
negative fold changes in green. B) Key components of the excitation–contraction system: Action potential ﬁring causes an inward Ca2+ current to enter the myocyte via CaV1.2 channels.
The inﬂux of Ca2+ ions stimulates Ryanodine receptors (RyR) to release additional Ca2+ into the cytosol from the calsequestrin stores of the sarcoplasmic reticulum (SR), causing the
activation of Troponin C and the troponin–tropomyosin complex that mediates contraction. Cytosolic Ca2+ levels are then rapidly reduced by a combination of mechanisms including
Na+/Ca2+ exchange by NCX and pumping into the SR by the Phospoholamban (PLN)-regulated sarcoendoplasmic reticulum calcium ATPase (SERCA). Junctophilin helps to tether
the SR to the sarcolemma. Diagram was made with Servier Medical Art, with permission. C) Expression of excitation–contraction genes in iCMs. Gene expression data obtained
via microarray analysis was conﬁrmed using quantitative RT-PCR and normalized to expression levels present in embryonic cardiomyocytes (E14.5). Calsequestrin, CaV1.2, and
Phospholamban are most highly expressed in iCMs generated by HGMT and HNGMT, the factor combinations that produced the most GCaMP+ cells. Data are presented as
means ± SEM. ⁎ denotes p b 0.05 for increase in expression compared to GMT.
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Fig. 6. iCMs derived from adult cardiac ﬁbroblasts. A) Quantiﬁcation of functional cardiac ﬁbroblast-derived iCMs using GCaMP activity. Functional iCMs were identiﬁed on the basis
of repeated GCaMP oscillation in 10 s movies made at 14 days post-induction. Activity is expressed as the percentage of cells displaying repeated GCaMP oscillation in 10 s movies
divided by the total number of cells per ﬁeld. Data are presented as means ± SEM. ⁎ denotes p b 0.05 in comparison to GMT. # denotes p b 0.05 in comparison to HGMT. B) GCaMP
activity recorded in a typical cardiac ﬁbroblast-derived iCM on Day 14 post-induction. Top panel is a single frame of Supplemental Movie S7, which shows both GCaMP activity and
spontaneous contraction. Lower panel shows oscillation in GCaMP ﬂuorescence at the region indicated by the white arrow, above. Scale bar 50 μm. C) Immunocytochemical analysis
of cardiac ﬁbroblast-derived iCMs, 14 days post-induction. Cardiomyocyte markers cardiac Troponin T (cTnT), α-myosin heavy chain (α-MHC), and sarcomeric α-actinin are
expressed in HNGMT-iCMs. Regions in white boxes are enlarged in insets to show sarcomere structure. Putative smooth muscle cells were also detected by staining for smooth
muscle myosin heavy chain (smMHC, Myh11). DAPI stain (blue) marks nuclei. Scale bars 50 μm.
105R.C. Addis et al. / Journal of Molecular and Cellular Cardiology 60 (2013) 97–106using Myocardin will require active suppression of the smooth muscle
phenotype in order to produce functional iCMs.
Previous publications reported an inhibitory role of Nkx2.5 in screens
for cardiac reprogramming factors [1,5]. Since the greatmajority of iCMs
generated in these screens were not functional (i.e. not beating), it is
conceivable that Nkx2.5 may decrease the overall number of cells that
express a given marker while increasing the proportion that are func-
tional. Although we demonstrated the effectiveness of HNGMT in both
MEFs and adult mouse cardiac ﬁbroblasts, it may still be the case that
different cell types – or cells from different species – aremost effectively
reprogrammed by differing sets of factors. This could be due to the
presence or absence of endogenous cofactors, the relative accessibility
of crucial regions of chromatin, or differences in proliferative capacity
and metabolic state among cell sources. Given the array of variables,
the ability to quantify functional iCMs will be essential to the advance-
ment of the ﬁeld.
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aMCFs: adult mouse cardiac ﬁbroblasts
α-MHC: alpha-myosin heavy chain
cTnT: cardiac Troponin T
GCaMP: genetically encoded calcium indicator, composite of GFP and CaM
GECI: genetically encoded calcium indicator
iCM: induced cardiomyocyte
IFU/mL: infectious units per milliliter
MEFs: mouse embryonic ﬁbroblasts
rtTA: reverse tetracycline transactivator
smMHC: smooth muscle myosin heavy chain
